These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6989494)

  • 21. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
    Wood AW; Levin W; Lu AY; Ryan D; West SB; Yagi H; Mah HD; Jerina DM; Conney AH
    Mol Pharmacol; 1977 Nov; 13(6):1116-25. PubMed ID: 339055
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides.
    Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; Jerina DM; Conney AH
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1389-96. PubMed ID: 332178
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitory effect of hemin, chlorophyllin and related pyrrole pigments on the mutagenicity of benzo[a]pyrene and its metabolites.
    Arimoto S; Kan-yama K; Rai H; Hayatsu H
    Mutat Res; 1995 Dec; 345(3-4):127-35. PubMed ID: 8552134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutagenic action of benz(a)pyrene and its metabolites in the in vitro Salmonella typhimurium-microsomes test system].
    Tolcheev IuD; Khitrovo IA; Kobliakov VA
    Biull Eksp Biol Med; 1980 Aug; 90(8):208-10. PubMed ID: 6996763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity of K-region epoxides of polycyclic aromatic compounds: structure-activity relationship.
    Miyata N; Shudo K; Kitahara Y; Huang GF; Okamoto T
    Mutat Res; 1976 Nov; 37(2-3):187-91. PubMed ID: 794704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and mutagenicity of 5-alkyl-substituted chrysene-1,2-diol-3,4-epoxides.
    Amin S; Huie K; Balanikas G; Hecht SS
    Carcinogenesis; 1988 Dec; 9(12):2305-8. PubMed ID: 3191576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and mutagenicity of 6,10-dimethylbenzo[a]-pyrene.
    Sullivan PD; Ellis LE; Bannoura F; Roach SM
    Chem Biol Interact; 1983 Jun; 44(3):329-32. PubMed ID: 6347411
    [No Abstract]   [Full Text] [Related]  

  • 28. Di-epoxides of the three isomeric dicyclopenta-fused pyrenes: ultimate mutagenic active agents.
    Otero-Lobato MJ; Kaats-Richters VE; Havenith RW; Jenneskens LW; Seinen W
    Mutat Res; 2004 Nov; 564(1):39-50. PubMed ID: 15474409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of 1-, 3- and 6-nitrosobenzo[a]pyrene in Salmonella typhimurium and Chinese hamster ovary cells.
    Heflich RH; Unruh LE; Thornton-Manning JR; von Tungeln LS; Fu PP
    Mutat Res; 1989 Apr; 225(4):157-63. PubMed ID: 2648140
    [No Abstract]   [Full Text] [Related]  

  • 30. Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells.
    Newbold RF; Brookes P
    Nature; 1976 May; 261(5555):52-4. PubMed ID: 1272374
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene.
    Kittle JD; Calle LM; Sullivan PD
    Mutat Res; 1981 Feb; 80(2):259-64. PubMed ID: 7010139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenicity of hydralazine in mammalian cells and bacteria.
    McQueen CA; Way BM; Queener SM
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):135-8. PubMed ID: 8430421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of hexahydrophenanthrenes and their oxirane derivatives.
    Crotti P; Di Bussolo V; Benetti D; Longo V; Gervasi PG
    J Environ Pathol Toxicol Oncol; 1994; 13(4):221-6. PubMed ID: 7658330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity of benzo(a)pyrene-3-O-glucuronide, a biliary metabolite of benzo(a)pyrene.
    Chipman JK; Millburn P; Brooks TM
    Toxicol Lett; 1983 Jul; 17(3-4):361-2. PubMed ID: 6312639
    [No Abstract]   [Full Text] [Related]  

  • 35. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene.
    Hu X; Xia H; Srivastava SK; Pal A; Awasthi YC; Zimniak P; Singh SV
    Cancer Res; 1998 Dec; 58(23):5340-3. PubMed ID: 9850062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective fluorescence quenching of benzo[a]pyrene and a mutagenic diol expoxide derivative in mouse cells.
    Wade CG; Baker DE; Bartholomew JC
    Biochemistry; 1978 Oct; 17(20):4332-7. PubMed ID: 708717
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolic activation of chrysene by hamster embryo cells.
    Hodgson RM; Pal K; Grover PL; Sims P
    Carcinogenesis; 1982; 3(9):1051-6. PubMed ID: 7139861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of anti-7,8-dihydroxy-9,10-epoxy-7,8,9, 10-tetrahydro-11-methylbenzo[a]pyrene and its reaction with DNA.
    Lin JM; Desai D; Chung L; Hecht SS; Amin S
    Chem Res Toxicol; 1999 Apr; 12(4):341-6. PubMed ID: 10207123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenicity of benzo[a]pyrene and thirteen of its derivatives in C3H/fCum mice.
    Kouri RE; Wood AW; Levin W; Rude TH; Yagi H; Mah HD; Jerina DM; Conney AH
    J Natl Cancer Inst; 1980 Mar; 64(3):617-23. PubMed ID: 6766516
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
    Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K
    Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.